Ramos Pinheiro, RDiamantino, FCabete, JBrasileiro, ABaptista, JPaiva Lopes, MJ2023-10-062023-10-062017-12Int J Dermatol . 2017 Dec;56(12):1461-1464.http://hdl.handle.net/10400.17/4709engHSAC DERAdolescentChildAdalimumab / therapeutic useBiological Products / adverse effectsBiological Products / therapeutic use*HumansFemaleMaleChild, PreschoolDermatologic Agents / adverse effectsDermatologic Agents / therapeutic use*Drug Substitution / trends*Etanercept / therapeutic useInfliximab / therapeutic usePsoriasis / drug therapy*Retrospective StudiesSeverity of Illness IndexUstekinumab / therapeutic useSwitching Biologics in Severe Pediatric Psoriasis: a Retrospective Analysisother10.1111/ijd.13752